Related Experiment Videos
A systematic review of integrative oncology programs
D M Seely1, L C Weeks, S Young
1Ottawa Integrative Cancer Centre, Ottawa, ON. ; Canadian College of Naturopathic Medicine, Toronto, ON. ; Ottawa Hospital Research Institute, Ottawa, ON.
Current Oncology (Toronto, Ont.)
|January 10, 2013
Summary
Integrative oncology programs are increasing, offering whole-person, patient-centered cancer care. While sharing a common vision, these programs vary in their structure and operational models.
Area of Science:
- Oncology
- Integrative Medicine
- Healthcare Program Development
Background:
- The field of oncology is evolving to incorporate a more holistic approach to patient care.
- Integrative oncology programs aim to combine conventional and complementary therapies for cancer patients.
- Understanding the landscape of existing integrative oncology programs is crucial for future development and research.
Purpose of the Study:
- To systematically review and summarize the existing research literature on integrative oncology programs.
- To identify common characteristics and variations among different integrative oncology program models.
- To provide an overview of the operational aspects, including funding, patient referral, and care delivery.
Main Methods:
- A systematic search of 9 electronic databases, relevant journals, and conference abstracts was performed.
- Two independent investigators screened titles and abstracts for programs combining complementary and conventional cancer care.
- Descriptive data were extracted from included articles based on predefined concepts.
Main Results:
- The review identified 29 integrative oncology programs, primarily located in the United States and England.
- Over half of the programs operate within hospitals, with patient self-referral being the most common intake method.
- Programs are funded through diverse sources including donations, cancer agencies, and private foundations, with many maintaining research or evaluation components.
Conclusions:
- The research literature indicates a growing number of integrative oncology programs worldwide.
- These programs share a commitment to patient-centered, whole-person care.
- Despite a common vision, significant diversity exists in the structural and operational models of these programs.
Related Concept Videos
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...